Rockefeller Capital Management L.P. Kal Vista Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$8.16 - $15.1 $595 - $1,102	73 Added 5.84%	1,323 $13,000
Q3 2021 Nov 12, 2021	BUY	$17.11 - $24.49 $4,277 - $6,122	250 Added 25.0%	1,250 $21,000
Q4 2020 Feb 12, 2021	SELL	$12.88 - $19.47 $6,440 - $9,735	-500 Reduced 33.33%	1,000 $18,000
Q4 2019 Feb 07, 2020	BUY	$10.31 - $17.81 $15,465 - $26,714	1,500 New	1,500 $27,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.